评估 2-硫代-2,3,5,6,7,8-六氢嘧啶并[4,5-d]嘧啶-4(1H)-酮类似物作为 GAA 激活剂。
Evaluation of 2-thioxo-2,3,5,6,7,8-hexahydropyrimido[4,5-d]pyrimidin-4(1H)-one analogues as GAA activators.
机构信息
NIH Chemical Genomic Center, National Human Genome Research Institute, National Institutes of Heath, 9800 Medical Center Drive, Rockville, MD, USA.
出版信息
Eur J Med Chem. 2010 May;45(5):1880-97. doi: 10.1016/j.ejmech.2010.01.027. Epub 2010 Feb 1.
Abstract
Pompe disease is a lysosomal storage disease (LSD) caused by a deficiency in the lysosomal enzyme acid alpha-glucosidase. In several LSDs, enzyme inhibitors have been used as small molecule chaperones to facilitate and increase the translocation of mutant protein from the endoplasmic reticulum to the lysosome. Enzyme activators with chaperone activity would be even more desirable as they would not inhibit the enzyme after translocation and might potentiate the activity of the enzyme that is successfully translocated. Herein we report our initial findings of a new series of acid alpha-glucosidase activators.
摘要
庞贝病是一种溶酶体贮积症（LSD），由溶酶体酶酸性α-葡萄糖苷酶缺乏引起。在几种 LSD 中，酶抑制剂已被用作小分子伴侣，以促进和增加突变蛋白从内质网向溶酶体的易位。具有伴侣活性的酶激活剂将更加理想，因为它们在易位后不会抑制酶，并且可能增强成功易位的酶的活性。本文报告了一系列新的酸性α-葡萄糖苷酶激活剂的初步研究结果。
相似文献
1
Evaluation of 2-thioxo-2,3,5,6,7,8-hexahydropyrimido[4,5-d]pyrimidin-4(1H)-one analogues as GAA activators.评估 2-硫代-2,3,5,6,7,8-六氢嘧啶并[4,5-d]嘧啶-4(1H)-酮类似物作为 GAA 激活剂。
Eur J Med Chem. 2010 May;45(5):1880-97. doi: 10.1016/j.ejmech.2010.01.027. Epub 2010 Feb 1.
2
Discovery of a novel noniminosugar acid α glucosidase chaperone series.发现新型非天然氨基糖酸α-葡萄糖苷酶伴侣系列。
J Med Chem. 2012 Sep 13;55(17):7546-59. doi: 10.1021/jm3005543. Epub 2012 Aug 17.
3
The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase.药物伴侣 1-脱氧野尻霉素增加了多种酸性α-葡萄糖苷酶突变体的活性和溶酶体转运。
Hum Mutat. 2009 Dec;30(12):1683-92. doi: 10.1002/humu.21121.
4
Systematic structure-activity study on potential chaperone lead compounds for acid α-glucosidase.对酸性α-葡萄糖苷酶潜在伴侣分子的先导化合物进行系统的构效关系研究。
ChemMedChem. 2012 Nov;7(11):1943-53. doi: 10.1002/cmdc.201200309. Epub 2012 Sep 11.
5
Endoplasmic reticulum stress induces autophagy through activation of p38 MAPK in fibroblasts from Pompe disease patients carrying c.546G>T mutation.内质网应激通过激活 Pompe 病患者携带 c.546G>T 突变的成纤维细胞中的 p38 MAPK 诱导自噬。
Mol Genet Metab. 2011 Dec;104(4):566-73. doi: 10.1016/j.ymgme.2011.09.005. Epub 2011 Sep 14.
6
Enzyme enhancers for the treatment of Fabry and Pompe disease.用于治疗法布里病和庞贝病的酶增强剂。
Mol Ther. 2015 Mar;23(3):456-64. doi: 10.1038/mt.2014.224. Epub 2014 Nov 20.
7
Carnitine is a pharmacological allosteric chaperone of the human lysosomal -glucosidase.肉碱是人类溶酶体β-葡萄糖苷酶的药理学变构伴侣。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):2068-2079. doi: 10.1080/14756366.2021.1975694.
8
Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding.在蛋白质聚集和折叠的细胞模型中合成和评估酯化 Hsp70 激动剂。
Bioorg Med Chem. 2019 Jan 1;27(1):79-91. doi: 10.1016/j.bmc.2018.11.011. Epub 2018 Nov 15.
10
Discovery and hit-to-lead optimization of novel allosteric glucokinase activators.新型变构葡萄糖激酶激活剂的发现和先导优化。
Bioorg Med Chem Lett. 2011 Sep 15;21(18):5417-22. doi: 10.1016/j.bmcl.2011.06.128. Epub 2011 Jul 18.
引用本文的文献
1
1,6--Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease.1,6--环磷醇环磺酰胺是治疗庞贝病的真正溶酶体α-葡萄糖苷酶稳定剂。
J Am Chem Soc. 2022 Aug 17;144(32):14819-14827. doi: 10.1021/jacs.2c05666. Epub 2022 Aug 2.
2
Pharmacological Chaperone Therapy for Pompe Disease.药物伴侣治疗庞贝病。
Molecules. 2021 Nov 29;26(23):7223. doi: 10.3390/molecules26237223.
3
Carnitine is a pharmacological allosteric chaperone of the human lysosomal -glucosidase.肉碱是人类溶酶体β-葡萄糖苷酶的药理学变构伴侣。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):2068-2079. doi: 10.1080/14756366.2021.1975694.
4
Second-Generation Pharmacological Chaperones: Beyond Inhibitors.第二代药理学伴侣：超越抑制剂。
Molecules. 2020 Jul 9;25(14):3145. doi: 10.3390/molecules25143145.
5
Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase.发现、构效关系及非抑制性小分子葡萄糖脑苷脂酶伴侣的生物学评价。
J Med Chem. 2012 Jun 28;55(12):5734-48. doi: 10.1021/jm300063b. Epub 2012 Jun 8.
6
Non-iminosugar glucocerebrosidase small molecule chaperones.非亚氨基糖葡萄糖脑苷脂酶小分子伴侣
Medchemcomm. 2012 Jan;3(1):56-60. doi: 10.1039/C1MD00200G. Epub 2011 Oct 24.
7
High throughput screening for small molecule therapy for Gaucher disease using patient tissue as the source of mutant glucocerebrosidase.利用患者组织作为突变葡萄糖脑苷脂酶的来源，进行戈谢病小分子治疗的高通量筛选。
PLoS One. 2012;7(1):e29861. doi: 10.1371/journal.pone.0029861. Epub 2012 Jan 17.
8
A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide.一种使用天然底物葡萄糖神经酰胺的高通量葡萄糖脑苷脂酶测定法。
Anal Bioanal Chem. 2012 Jan;402(2):731-9. doi: 10.1007/s00216-011-5496-z. Epub 2011 Oct 28.
9
Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders.鉴定和表征用于纠正溶酶体贮积症中酶缺陷的药理学伴侣分子。
Assay Drug Dev Technol. 2011 Jun;9(3):213-35. doi: 10.1089/adt.2011.0370.
10
High throughput screening for inhibitors of alpha-galactosidase.α-半乳糖苷酶抑制剂的高通量筛选
Curr Chem Genomics. 2010 Dec 3;4:67-73. doi: 10.2174/1875397301004010067.
本文引用的文献
1
Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease.庞贝病患者成纤维细胞中突变α-葡萄糖苷酶活性的药理学增强
Mol Ther. 2007 Mar;15(3):508-514. doi: 10.1038/sj.mt.6300074. Epub 2016 Dec 8.
2
A new resorufin-based alpha-glucosidase assay for high-throughput screening.一种用于高通量筛选的基于试卤灵的新型α-葡萄糖苷酶检测方法。
Anal Biochem. 2009 Jul 1;390(1):79-84. doi: 10.1016/j.ab.2009.04.010. Epub 2009 Apr 14.
3
Active-site-specific chaperone therapy for Fabry disease. Yin and Yang of enzyme inhibitors.法布里病的活性位点特异性伴侣蛋白疗法。酶抑制剂的阴阳之道。
FEBS J. 2007 Oct;274(19):4962-71. doi: 10.1111/j.1742-4658.2007.06041.x.
4
Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II.化学伴侣可改善糖原贮积病II型中突变α-葡萄糖苷酶的转运并增强其稳定性。
Mol Genet Metab. 2007 Jan;90(1):49-57. doi: 10.1016/j.ymgme.2006.09.010. Epub 2006 Nov 13.
5
New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy.溶酶体贮积症的新治疗选择：酶替代疗法、小分子疗法和基因疗法。
Hum Genet. 2007 Mar;121(1):1-22. doi: 10.1007/s00439-006-0280-4. Epub 2006 Nov 7.
6
Characterization of human saposins by NMR spectroscopy.通过核磁共振光谱法对人鞘脂激活蛋白进行表征。
Biochemistry. 2006 Apr 25;45(16):5206-16. doi: 10.1021/bi051944+.
7
Substituted 5,5'-diphenyl-2-thioxoimidazolidin-4-one as CB1 cannabinoid receptor ligands: synthesis and pharmacological evaluation.作为CB1大麻素受体配体的取代5,5'-二苯基-2-硫代咪唑啉-4-酮：合成与药理学评价
J Med Chem. 2005 Apr 7;48(7):2509-17. doi: 10.1021/jm049263k.
8
Glycogenosis type II: identification and expression of three novel mutations in the acid alpha-glucosidase gene causing the infantile form of the disease.II型糖原贮积病：酸性α-葡萄糖苷酶基因中导致婴儿型疾病的三个新突变的鉴定与表达
Mol Genet Metab. 2004 Mar;81(3):203-8. doi: 10.1016/j.ymgme.2003.11.011.
9
Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II.溶酶体α-葡萄糖苷酶基因（GAA）中的22种新突变突出了II型糖原贮积病的基因型-表型相关性。
Hum Mutat. 2004 Jan;23(1):47-56. doi: 10.1002/humu.10286.
10
Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease).酸性α-葡萄糖苷酶缺乏症（糖原贮积症II型，庞贝病）。
Curr Mol Med. 2002 Mar;2(2):145-66. doi: 10.2174/1566524024605789.
Zotero 插件